Alzheimer disease: Report of the council on scientific affairs

Rosalie Guttman, Roy D Altman, Nancy H. Nielsen, Barry D. Dickinson

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Alzheimer disease (AD) takes a heavy economic, social, physical, and psychological toll on patients, families, and society. Because of the increasing life expectancy in the United States, AD is expected to afflict approximately 14 million people within the next few decades. There is currently no cure, only interventions that can temporarily ameliorate the profound cognitive losses and behavioral manifestations of the disorder. Community services are fragmented and underutilized. Physicians, in their traditional role as gatekeepers, can encourage more families to use supportive services. This article reviews the guidelines on the diagnosis and treatment of AD of the Agency for Health Care Policy and Research, the American Academy of Neurology, the Veterans Health Administration, and the American Psychiatric Association. Although these guidelines contain valuable information, they do not adequately address the role of the family physician and the need for continuity of care. Recommendations regarding AD from the Council on Scientific Affairs, which were adopted as American Medical Association policy in December 1997, are included in this article.

Original languageEnglish (US)
Pages (from-to)347-353
Number of pages7
JournalArchives of Family Medicine
Volume8
Issue number4
StatePublished - 1999
Externally publishedYes

Fingerprint

Alzheimer Disease
United States Agency for Healthcare Research and Quality
Guidelines
Veterans Health
United States Department of Veterans Affairs
Continuity of Patient Care
Social Welfare
Family Physicians
American Medical Association
Life Expectancy
Economics
Psychology
Physicians
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Guttman, R., Altman, R. D., Nielsen, N. H., & Dickinson, B. D. (1999). Alzheimer disease: Report of the council on scientific affairs. Archives of Family Medicine, 8(4), 347-353.

Alzheimer disease : Report of the council on scientific affairs. / Guttman, Rosalie; Altman, Roy D; Nielsen, Nancy H.; Dickinson, Barry D.

In: Archives of Family Medicine, Vol. 8, No. 4, 1999, p. 347-353.

Research output: Contribution to journalArticle

Guttman, R, Altman, RD, Nielsen, NH & Dickinson, BD 1999, 'Alzheimer disease: Report of the council on scientific affairs', Archives of Family Medicine, vol. 8, no. 4, pp. 347-353.
Guttman R, Altman RD, Nielsen NH, Dickinson BD. Alzheimer disease: Report of the council on scientific affairs. Archives of Family Medicine. 1999;8(4):347-353.
Guttman, Rosalie ; Altman, Roy D ; Nielsen, Nancy H. ; Dickinson, Barry D. / Alzheimer disease : Report of the council on scientific affairs. In: Archives of Family Medicine. 1999 ; Vol. 8, No. 4. pp. 347-353.
@article{0da4ed4d839641a9988ea445ae10da2e,
title = "Alzheimer disease: Report of the council on scientific affairs",
abstract = "Alzheimer disease (AD) takes a heavy economic, social, physical, and psychological toll on patients, families, and society. Because of the increasing life expectancy in the United States, AD is expected to afflict approximately 14 million people within the next few decades. There is currently no cure, only interventions that can temporarily ameliorate the profound cognitive losses and behavioral manifestations of the disorder. Community services are fragmented and underutilized. Physicians, in their traditional role as gatekeepers, can encourage more families to use supportive services. This article reviews the guidelines on the diagnosis and treatment of AD of the Agency for Health Care Policy and Research, the American Academy of Neurology, the Veterans Health Administration, and the American Psychiatric Association. Although these guidelines contain valuable information, they do not adequately address the role of the family physician and the need for continuity of care. Recommendations regarding AD from the Council on Scientific Affairs, which were adopted as American Medical Association policy in December 1997, are included in this article.",
author = "Rosalie Guttman and Altman, {Roy D} and Nielsen, {Nancy H.} and Dickinson, {Barry D.}",
year = "1999",
language = "English (US)",
volume = "8",
pages = "347--353",
journal = "Archives of Family Medicine",
issn = "1063-3987",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Alzheimer disease

T2 - Report of the council on scientific affairs

AU - Guttman, Rosalie

AU - Altman, Roy D

AU - Nielsen, Nancy H.

AU - Dickinson, Barry D.

PY - 1999

Y1 - 1999

N2 - Alzheimer disease (AD) takes a heavy economic, social, physical, and psychological toll on patients, families, and society. Because of the increasing life expectancy in the United States, AD is expected to afflict approximately 14 million people within the next few decades. There is currently no cure, only interventions that can temporarily ameliorate the profound cognitive losses and behavioral manifestations of the disorder. Community services are fragmented and underutilized. Physicians, in their traditional role as gatekeepers, can encourage more families to use supportive services. This article reviews the guidelines on the diagnosis and treatment of AD of the Agency for Health Care Policy and Research, the American Academy of Neurology, the Veterans Health Administration, and the American Psychiatric Association. Although these guidelines contain valuable information, they do not adequately address the role of the family physician and the need for continuity of care. Recommendations regarding AD from the Council on Scientific Affairs, which were adopted as American Medical Association policy in December 1997, are included in this article.

AB - Alzheimer disease (AD) takes a heavy economic, social, physical, and psychological toll on patients, families, and society. Because of the increasing life expectancy in the United States, AD is expected to afflict approximately 14 million people within the next few decades. There is currently no cure, only interventions that can temporarily ameliorate the profound cognitive losses and behavioral manifestations of the disorder. Community services are fragmented and underutilized. Physicians, in their traditional role as gatekeepers, can encourage more families to use supportive services. This article reviews the guidelines on the diagnosis and treatment of AD of the Agency for Health Care Policy and Research, the American Academy of Neurology, the Veterans Health Administration, and the American Psychiatric Association. Although these guidelines contain valuable information, they do not adequately address the role of the family physician and the need for continuity of care. Recommendations regarding AD from the Council on Scientific Affairs, which were adopted as American Medical Association policy in December 1997, are included in this article.

UR - http://www.scopus.com/inward/record.url?scp=0033238144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033238144&partnerID=8YFLogxK

M3 - Article

C2 - 10418544

AN - SCOPUS:0033238144

VL - 8

SP - 347

EP - 353

JO - Archives of Family Medicine

JF - Archives of Family Medicine

SN - 1063-3987

IS - 4

ER -